VivoSeq
Psychiatry

Addiction

1

Pipeline Programs↗

8

Active Trials↗

3

Companies Involved↗

Addiction is an early-stage landscape with 1 program across 3 companies. The most active players are Novo Nordisk, Embera NeuroTherapeutics, Inc., Quit Center LLC.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

22/100

Mech. Concentration

100/100

Completion Rate

75/100

Attrition Rate

19/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novo Nordisk logo

Novo Nordisk

1 program

Phase 2E

Embera NeuroTherapeutics, Inc.

0 programs

PreclinicalQ

Quit Center LLC

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

Semaglutide

Novo Nordisk

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

32

clinical trials

Completed18 · 56%
Recruiting6 · 19%
Terminated4 · 13%
Withdrawn2 · 6%
Not yet recruiting1 · 3%
Active, not recruiting1 · 3%

Clinical Trials

Trial Activity

32 trials

Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Recruiting·DDr. med. Marcus Herdener·Phase 2·NCT06125054·120 enrolled
Addiction Potential of Very Low Nicotine Filtered Little Cigars
Recruiting·OOhio State University Comprehensive Cancer Center·Phase 4·NCT06630728·50 enrolled
Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
Recruiting·—·N/A·NCT05992272·300 enrolled
Semaglutide Therapy for Alcohol Reduction (STAR): A Proof-of-Concept Phase II Clinical Trial
Recruiting·National Institute on Drug Abuse (NIDA)·Phase 2·NCT06015893·80 enrolled
Mobile Restriction on Dopamine Transporter
Recruiting·PPusan National University Hospital·Preclinical·NCT07663474·30 enrolled
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Recruiting·TThe University of Texas Health Science Center, Houston·Preclinical·NCT07298902·100 enrolled
Observational Study Evaluating a Smoking Cessation Program and Its Association With Long-Term Smoking Abstinence
Active, not recruiting·QQuit Center LLC·N/A·NCT06746025·371 enrolled
Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing
Not yet recruiting·VVA Office of Research and Development·N/A·NCT07141394·7,908 enrolled
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
Completed·PPsychiatric University Hospital, Zurich·Phase 4·NCT02626494·71 enrolled
Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT00701532·29 enrolled
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Completed·UUniversity of Minnesota·Phase 2·NCT00000244
Brain Networks and Addiction Susceptibility
Completed·National Institute on Drug Abuse (NIDA)·Phase 1·NCT01924468·76 enrolled
Investigation of Cocaine Addiction Using mGluR5 PET and fMRI
Completed·YYale University·Phase 1·NCT03471182·32 enrolled
CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery
Completed·UUniversity of Pennsylvania·Phase 2·NCT01587196·72 enrolled
Do Flavors Increase the Addiction Potential of Nicotine?
Completed·UUniversity of Vermont·Phase 2·NCT04696380·19 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)